Clinical Trial Update: XTR003 PET Radiotracer for the Detection of Viable Myocardium [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for XTR003 PET radiotracer aiming to detect viable myocardium in ischemic heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease

Drugs mentioned

• XTR003 (XTR003)

Snippet

Sponsor: Sinotau Pharmaceutical Group | Conditions: Ischemic Heart Disease (IHD) | Phase 2 | Status: COMPLETED